chr1-16022674-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_004070.4(CLCNKA):c.55C>T(p.Gln19Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000339 in 1,563,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000072 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000030 ( 0 hom. )
Consequence
CLCNKA
NM_004070.4 stop_gained
NM_004070.4 stop_gained
Scores
2
2
3
Clinical Significance
Conservation
PhyloP100: 1.36
Genes affected
CLCNKA (HGNC:2026): (chloride voltage-gated channel Ka) This gene is a member of the CLC family of voltage-gated chloride channels. The encoded protein is predicted to have 12 transmembrane domains, and requires a beta subunit called barttin to form a functional channel. It is thought to function in salt reabsorption in the kidney and potassium recycling in the inner ear. The gene is highly similar to CLCNKB, which is located 10 kb downstream from this gene. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-16022674-C-T is Pathogenic according to our data. Variant chr1-16022674-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 587598.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=2, Pathogenic=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLCNKA | NM_004070.4 | c.55C>T | p.Gln19Ter | stop_gained | 2/20 | ENST00000331433.5 | NP_004061.3 | |
CLCNKA | NM_001042704.2 | c.55C>T | p.Gln19Ter | stop_gained | 2/20 | NP_001036169.1 | ||
CLCNKA | NM_001257139.2 | c.55C>T | p.Gln19Ter | stop_gained | 2/19 | NP_001244068.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLCNKA | ENST00000331433.5 | c.55C>T | p.Gln19Ter | stop_gained | 2/20 | 1 | NM_004070.4 | ENSP00000332771 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152144Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
11
AN:
152144
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000108 AC: 19AN: 176740Hom.: 0 AF XY: 0.000106 AC XY: 10AN XY: 94070
GnomAD3 exomes
AF:
AC:
19
AN:
176740
Hom.:
AF XY:
AC XY:
10
AN XY:
94070
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000298 AC: 42AN: 1411732Hom.: 0 Cov.: 30 AF XY: 0.0000287 AC XY: 20AN XY: 697884
GnomAD4 exome
AF:
AC:
42
AN:
1411732
Hom.:
Cov.:
30
AF XY:
AC XY:
20
AN XY:
697884
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74450
GnomAD4 genome
AF:
AC:
11
AN:
152260
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Sensorineural hearing loss disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Genetics Research Center, University of Social Welfare and Rehabilitation Sciences | Sep 30, 2020 | - - |
Bartter disease type 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Aug 07, 2018 | - - |
Bartter disease type 4B Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Aug 07, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Benign
N
MutationTaster
Benign
A;A;A;A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at